Healthtech Startups

Modulight develops a platform to treat severe neurological diseases through scientific innovation and clinical expertise.

1 investor

Moggie is a digital health platform that helps cat owners track and understand their pets' wellbeing by identifying behavioral and health changes. The service is designed for pet owners who want to monitor their cats' health with greater confidence and early detection of potential issues.

1 investor

MoldCo is a healthcare technology platform connecting patients with mold-trained providers to diagnose and treat mold-related illness through virtual care, testing, and personalized treatment protocols. The service is available across the United States and offers symptom assessment, laboratory testing, and ongoing medical support for individuals experiencing health complications from mold exposure.

1 investor

Molecular Designs develops and sells research assays and molecular diagnostic panels designed to run on standard PCR platforms, serving research labs seeking cost-effective and efficient testing solutions. The company offers direct-to-customer purchasing with customization options and supply chain support.

1 investor

MT develops cancer-specific molecular imaging agents (probes) targeting a common oncoprotein in the tumor microenvironment, intended for use with imaging modalities such as CT, PET, MRI, SPECT and ultrasound. The agents are aimed at early detection and diagnosis of aggressive tumors across multiple cancer types for clinical cancer management.

1 investor

Molecular Instruments develops HCR (hybridization chain reaction) imaging products for enzyme-free, multiplex, quantitative in situ hybridization and immunofluorescence, enabling detection of RNA and protein targets. Its products serve researchers in life sciences performing high-resolution imaging and expression profiling of cells and tissue samples.

1 investor

Moleculera Labs offers the Autoimmune Brain Panel, a diagnostic blood test that identifies autoimmune dysfunction in patients with treatment-resistant neuropsychiatric and behavioral symptoms. The test measures autoimmune antibodies targeting brain receptors to help clinicians distinguish autoimmune-driven conditions from primary psychiatric or neurologic disorders.

1 investor

MoleMap provides skin cancer detection and diagnosis services, including full-body mole mapping, dermatologist-diagnosed skin checks, imaging with ongoing monitoring, and skin cancer treatment. It serves individuals and workplaces through clinics in New Zealand and Australia, with additional GP referral and workplace screening programs.

1 investor

MoleSense is a Switzerland-based company whose website references future health-related products, applications, wearable devices, biomarker and clinical data processing. The page is a privacy policy and gives limited detail, but suggests a focus on health monitoring or diagnostics involving wearables and biomarker data.

1 investor

Molina Healthcare is a Fortune 500 health care organization operating across multiple U.S. states. The company provides health insurance and related healthcare services to diverse populations.

1 investor

Molly Health builds a unified interface platform that integrates claims data, benefit decisioning logic, and consumer-facing tools to guide patients toward appropriate and accessible care decisions across fragmented health insurance systems.

1 investor

Molmir is an academic spinout developing technology to observe how molecules "move" and change shape based on liquid-liquid phase separation research, enabling previously undruggable dynamic molecules to be targeted in drug discovery. It focuses on diseases without established treatments such as ALS, Alzheimer's disease, cancer, and heart disease.

1 investor

Mölnlycke is a MedTech company that develops wound care, surgical, and antiseptic solutions for healthcare providers and professionals globally. The company serves healthcare systems and providers seeking to improve patient outcomes while reducing environmental impact.

1 investor

Mom's Meals provides medically tailored meals accessible through 69 U.S. locations, either as a covered benefit through health plans or available for direct purchase to support nutrition needs.

1 investor

Momentum Clinical Research (formerly PCRN) operates a network of 19 clinical research sites across Australia and New Zealand, conducting phase I to IV clinical trials across most therapeutic areas. It partners with pharmaceutical and biotech companies to run studies and recruits local participants as trial volunteers.

1 investor

Momentum TX develops therapeutics targeting the aging process to treat age-related conditions of the central and peripheral nervous systems, with a focus on neurodegeneration. It uses in silico, in vitro, and in vivo methods and proteomics data to identify drug targets that restore protein configurations altered in the aged brain.

1 investor

MomJunction is a parenting and health information resource that features medical content reviewed by a global team of healthcare professionals across pediatrics, obstetrics, gynecology, dermatology, dentistry, and related fields.

1 investor

Mon4t provides quantitative neurological assessment technology that enables remote testing and monitoring of neurological symptoms for clinical research, drug development, telemedicine, and screening applications. The platform serves patients, researchers, clinicians, and telehealth providers across preclinical and commercial stages of care.

1 investor

Monarch Clubs is a wellness company that combines health education, technology, and accessibility to provide integrated health and lifestyle guidance. The company serves individuals seeking comprehensive wellness solutions through a multi-disciplinary, globally connected approach.

1 investor

Monarch Health Systems develops a platform for pediatric surgical care quality and safety management. The platform helps children's hospitals track and improve clinical outcomes and operational performance.

1 investor

Monarch House provides therapeutic and educational services for individuals with autism spectrum disorder and other developmental disorders, supporting their social, behavioral, communication, and vocational development. The organization operates centers across Canada serving children and families with complex behavioral and developmental needs.

1 investor

MONCYTE Health develops a personalized diagnostic test that helps clinicians choose more effective cholesterol-lowering treatments for patients with high cholesterol. The test is aimed at optimizing treatment and prevention of cardiovascular disease.

1 investor

Mondego Bio develops PTPN2 (protein tyrosine phosphatase non-receptor type 2) inhibitors as immuno-oncology therapies, aiming to enhance IFNγ signaling to make tumor cells more susceptible to immune attack. The company focuses on small-molecule cancer immunotherapy drug candidates with oral bioavailability and improved safety profiles.

1 investor

ClinLife operates an online portal that matches patients with clinical trials suited to their health profile, guiding them through questionnaires and a medical team to find suitable studies. The service is available in over 50 countries and 35 languages, and also helps trial organizers reach eligible patients.

1 investor